help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2005-0134
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data Figure
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, W.
Right arrow Articles by Garabedian, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, W.
Right arrow Articles by Garabedian, M. J.
Molecular Endocrinology 19 (9): 2273-2282
Copyright © 2005 by The Endocrine Society

Androgen Receptor Mutations Identified in Prostate Cancer and Androgen Insensitivity Syndrome Display Aberrant ART-27 Coactivator Function

Wenhui Li, Claudio N. Cavasotto, Timothy Cardozo, Susan Ha, Thoa Dang, Samir S. Taneja, Susan K. Logan and Michael J. Garabedian

Departments of Microbiology (W.L., T.D., M.J.G.), Urology (W.L., S.H., T.D., S.S.T., S.K.L., M.J.G.), and Pharmacology (S.K.L., T.C.), New York University Cancer Institute, New York University School of Medicine, New York, New York 10016; and Molsoft (C.N.C.), La Jolla, California 92037

Address all correspondence and requests for reprints to: Susan K. Logan or Michael J. Garabedian, New York University Cancer Institute, New York University School of Medicine, 550 First Avenue, New York, New York 10016. E-mail for M.J.G.: garabm01{at}med.nyu.edu; E-mail for S.K.L.: logans02{at}med.nyu.edu.

The transcriptional activity of the androgen receptor (AR) is modulated by interactions with coregulatory molecules. It has been proposed that aberrant interactions between AR and its coregulators may contribute to diseases related to AR activity, such as prostate cancer and androgen insensitivity syndrome (AIS); however, evidence linking abnormal receptor-cofactor interactions to disease is scant. ART-27 is a recently identified AR N-terminal coactivator that is associated with AR-mediated growth inhibition. Here we analyze a number of naturally occurring AR mutations identified in prostate cancer and AIS for their ability to affect AR response to ART-27. Although the vast majority of AR mutations appeared capable of increased activation in response to ART-27, an AR mutation identified in prostate cancer (AR P340L) and AIS (AR E2K) show reduced transcriptional responses to ART-27, whereas their response to the p160 class of coactivators was not diminished. Relative to the wild-type receptor, less ART-27 protein associated with the AR E2K substitution, consistent with reduced transcriptional response. Surprisingly, more ART-27 associated with AR P340L, despite the fact that the mutation decreased transcriptional activation in response to ART-27. Our findings suggest that aberrant AR-coactivator association interferes with normal ART-27 coactivator function, resulting in suppression of AR activity, and may contribute to the pathogenesis of diseases related to alterations in AR activity, such as prostate cancer and AIS.

NURSA Molecule Pages Link:

Nuclear Receptors:   AR
Coregulators:   ART-27  |  SRC-1  |  GRIP1
Ligands:   R1881



This article has been cited by other articles:


Home page
Cancer Res.Home page
J. C. Nwachukwu, P. Mita, R. Ruoff, S. Ha, Q. Wang, S. J. Huang, S. S. Taneja, M. Brown, W. L. Gerald, M. J. Garabedian, et al.
Genome-Wide Impact of Androgen Receptor Trapped clone-27 Loss on Androgen-Regulated Transcription in Prostate Cancer Cells
Cancer Res., April 1, 2009; 69(7): 3140 - 3147.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
W. Chen, T. Dang, R. D. Blind, Z. Wang, C. N. Cavasotto, A. B. Hittelman, I. Rogatsky, S. K. Logan, and M. J. Garabedian
Glucocorticoid Receptor Phosphorylation Differentially Affects Target Gene Expression
Mol. Endocrinol., August 1, 2008; 22(8): 1754 - 1766.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
I. P. Torra, N. Ismaili, J. E. Feig, C.-F. Xu, C. Cavasotto, R. Pancratov, I. Rogatsky, T. A. Neubert, E. A. Fisher, and M. J. Garabedian
Phosphorylation of Liver X Receptor {alpha} Selectively Regulates Target Gene Expression in Macrophages
Mol. Cell. Biol., April 15, 2008; 28(8): 2626 - 2636.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
J. C. Nwachukwu, W. Li, I. Pineda-Torra, H. Y. Huang, R. Ruoff, E. Shapiro, S. S. Taneja, S. K. Logan, and M. J. Garabedian
Transcriptional Regulation of the Androgen Receptor Cofactor Androgen Receptor Trapped Clone-27
Mol. Endocrinol., December 1, 2007; 21(12): 2864 - 2876.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
D. M. Lonard, R. B. Lanz, and B. W. O'Malley
Nuclear Receptor Coregulators and Human Disease
Endocr. Rev., August 1, 2007; 28(5): 575 - 587.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society